Canada Biotechnology & Medical Research

Helix BioPharma Corp (HBP)

Track

Track

Ticker: HBP Exchange: TOR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Helix BioPharma Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.0
Mehrling, Thomas Jorg Heinrich Senior Officer of Issuer Officer
Transaction date
Purchase
Price
394.29
Quantity 17,572 -33.3%
Value CA$4,850,575
3.0
Mehrling, Thomas Jorg Heinrich Senior Officer of Issuer Officer
Transaction date
Purchase
Price
475.78
Quantity 26,204
Value CA$2,076,113
3.0
Mehrling, Thomas Jorg Heinrich Senior Officer of Issuer Officer
Transaction date
Purchase
Price
300.04
Quantity 84,856
Value CA$2,152,926
3.0
Mehrling, Thomas Jorg Heinrich Senior Officer of Issuer Officer
Transaction date
Purchase
Price
0.95
Quantity 9,454,153
Value CA$8,981,445
2.3
Wilczewski, Jerzy 10% Security Holder of Issuer Large shareholder
Transaction date
Purchase
Price
0.75
Quantity 1,000 +51.0%
Value CA$100,000
2.3
Wilczewski, Jerzy 10% Security Holder of Issuer Large shareholder
Transaction date
Sale
Price
0.23
Quantity 14,327,778 -42.2%
Value CA$3,295,389
2.3
Wilczewski, Jerzy 10% Security Holder of Issuer Large shareholder
Transaction date
Purchase
Price
0.18
Quantity 2,777,778 +8.9%
Value CA$500,000
Leszczynski, Jerzy Alfred Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.18
Quantity 400,000 +23.8%
Value CA$72,000
Leszczynski, Jerzy Alfred Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.18
Quantity 400,000 +31.2%
Value CA$72,000
ANTAS, JACEK MAREK Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.18
Quantity 1,100,000 +52.6%
Value CA$198,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-07-29 2025-07-21 B Purchase
3.0
Mehrling, Thomas Jorg Heinrich

Senior Officer of Issuer

Officer
17,572 -33.3%
394.29
CA$4,850,575 		17,572 -33.3% 394.29 CA$4,850,575
2025-07-29 2025-07-17 B Purchase
3.0
Mehrling, Thomas Jorg Heinrich

Senior Officer of Issuer

Officer
26,204
475.78
CA$2,076,113 		26,204 475.78 CA$2,076,113
2025-05-22 2025-05-16 B Purchase
3.0
Mehrling, Thomas Jorg Heinrich

Senior Officer of Issuer

Officer
84,856
300.04
CA$2,152,926 		84,856 300.04 CA$2,152,926
2025-05-22 2025-05-16 B Purchase
3.0
Mehrling, Thomas Jorg Heinrich

Senior Officer of Issuer

Officer
9,454,153
0.95
CA$8,981,445 		9,454,153 0.95 CA$8,981,445
2026-08-10 2025-01-08 B Purchase
2.3
Wilczewski, Jerzy

10% Security Holder of Issuer

Large shareholder
1,000 +51.0%
0.75
CA$100,000 		1,000 +51.0% 0.75 CA$100,000
2024-07-26 2024-07-26 S Sale
2.3
Wilczewski, Jerzy

10% Security Holder of Issuer

Large shareholder
14,327,778 -42.2%
0.23
CA$3,295,389 		14,327,778 -42.2% 0.23 CA$3,295,389
2023-08-25 2023-08-21 B Purchase
2.3
Wilczewski, Jerzy

10% Security Holder of Issuer

Large shareholder
2,777,778 +8.9%
0.18
CA$500,000 		2,777,778 +8.9% 0.18 CA$500,000
2023-08-25 2023-08-21 B Purchase
Leszczynski, Jerzy Alfred

Director of Issuer

Non-Executive Director
400,000 +23.8%
0.18
CA$72,000 		400,000 +23.8% 0.18 CA$72,000
2022-11-08 2022-11-03 B Purchase
Leszczynski, Jerzy Alfred

Director of Issuer

Non-Executive Director
400,000 +31.2%
0.18
CA$72,000 		400,000 +31.2% 0.18 CA$72,000
2022-11-08 2022-11-03 B Purchase
ANTAS, JACEK MAREK

Director of Issuer

Non-Executive Director
1,100,000 +52.6%
0.18
CA$198,000 		1,100,000 +52.6% 0.18 CA$198,000
Explore more

More insider trading research around Helix BioPharma Corp

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America